ArticleBioengineering (Basel, Switzerland)2025
Enhancing Melanoma Diagnosis in Histopathology with Deep Learning and Synthetic Data Augmentation.
Article in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial Intelligence for Computer-Aided Detection in Biomedical Applications.Bioengineering (Basel, Switzerland) · 2026Article
- Synthetic Melanoma Image Generation and Evaluation Using Generative Adversarial Networks.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Accurate diagnosis of melanoma using hematoxylin and eosin (H&E)-stained histological images is often challenged by the scarcity and imbalance of biomedical datasets, limiting the performance of deep learning models. This study investigates the impact of synthetic image generation, via generative adversarial networks (GAN), on training automatic classifiers based on the ResNet-18 architecture. Two experimental setups were designed: one using only real images and another combining real images with synthetic ones of the melanocytic nevus class to balance the dataset. Models were trained and evaluated at resolutions up to 1024 × 1024 pixels, employing standard classification metrics and the Fréchet Inception Distance (FID) to assess the quality of the generated images. The results suggest that although mixed models do not consistently outperform those trained exclusively on real data, they achieve competitive performance, particularly in terms of specificity and reduction in false negatives. This study supports the use of synthetic data as a complementary tool in scenarios where the acquisition of new samples is limited and lays the groundwork for future research in conditional generation and synthesis of malignant samples. In our best-performing model (1024 × 1024 px, 50 epochs, mixed dataset), we achieved an accuracy of 96.00%, a specificity of 97.00%, and a reduction in false negatives from 80 to 75 cases compared with real-only training. These results highlight the potential of synthetic augmentation to improve clinically relevant outcomes, particularly in reducing missed melanoma diagnoses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.